These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 21871373

  • 1. A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study.
    Hagman J, Gralla J, Sigel E, Ellert S, Dodge M, Gardner R, O'Lonergan T, Frank G, Wamboldt MZ.
    J Am Acad Child Adolesc Psychiatry; 2011 Sep; 50(9):915-24. PubMed ID: 21871373
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
    Modabbernia A, Rezaei F, Salehi B, Jafarinia M, Ashrafi M, Tabrizi M, Hosseini SM, Tajdini M, Ghaleiha A, Akhondzadeh S.
    CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
    [Abstract] [Full Text] [Related]

  • 4. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
    Kane JM, Correll CU, Goff DC, Kirkpatrick B, Marder SR, Vester-Blokland E, Sun W, Carson WH, Pikalov A, Assunção-Talbott S.
    J Clin Psychiatry; 2009 Oct; 70(10):1348-57. PubMed ID: 19906340
    [Abstract] [Full Text] [Related]

  • 5. A double-blind pilot study of risperidone in the treatment of conduct disorder.
    Findling RL, McNamara NK, Branicky LA, Schluchter MD, Lemon E, Blumer JL.
    J Am Acad Child Adolesc Psychiatry; 2000 Apr; 39(4):509-16. PubMed ID: 10761354
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Haas M, Delbello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumakar V.
    Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Asadabadi M, Mohammadi MR, Ghanizadeh A, Modabbernia A, Ashrafi M, Hassanzadeh E, Forghani S, Akhondzadeh S.
    Psychopharmacology (Berl); 2013 Jan; 225(1):51-9. PubMed ID: 22782459
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
    Turgay A, Binder C, Snyder R, Fisman S.
    Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
    [Abstract] [Full Text] [Related]

  • 14. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Lyons B, Grossman F.
    J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
    [Abstract] [Full Text] [Related]

  • 15. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS, Mancini DA, Srinivasan J, McCann S, Konarski JZ, Kennedy SH.
    Can J Clin Pharmacol; 2004 Feb; 11(2):e218-26. PubMed ID: 15520475
    [Abstract] [Full Text] [Related]

  • 16. A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia.
    Haas M, Unis AS, Armenteros J, Copenhaver MD, Quiroz JA, Kushner SF.
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):611-21. PubMed ID: 20035579
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Double-blind placebo-controlled trial of quetiapine in anorexia nervosa.
    Powers PS, Klabunde M, Kaye W.
    Eur Eat Disord Rev; 2012 Jul; 20(4):331-4. PubMed ID: 22535517
    [Abstract] [Full Text] [Related]

  • 19. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
    McDougle CJ, Holmes JP, Carlson DC, Pelton GH, Cohen DJ, Price LH.
    Arch Gen Psychiatry; 1998 Jul; 55(7):633-41. PubMed ID: 9672054
    [Abstract] [Full Text] [Related]

  • 20. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
    Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B.
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):482-93. PubMed ID: 26262903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.